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ABSTRACT
Natural products and related structures are an important source of
compounds with biological activity. Biotransformations of organic molecules
provides the ability to obtain new compounds which can be tested. This
technique has the advantage of enabling functionalized organic compounds
using enzymes in microorganisms through simple reactions, in a regio-and
stereoselective way, in mild conditions and avoiding polluting the
environment. In order to look for new active compounds, pure strains of
phytopatogenic fungi Penicillium sp. and Rhizopus sp., were used to
transform the sesquiterpene lactone (-)-achalensolide in a regio and
streoselective way to obtain one reduced metabolite, 11â,13-
dihydroachalensolide. A two stages standard protocol was used and after
isolation and purification of product, IR, 1H and 13C NMR spectroscopy
allowed to confirm its structure. 1,1-diphenyl-2-picrylhydrazyl and Artemia
salina in vitro assays were done to test starting material and product
obtained. They showed weak similar activity when compared to reference
compounds, so structural modification had no effect on it.
 2014 Trade Science Inc. - INDIA
INTRODUCTION
The sesquiterpene lactones are an important group
of natural compounds, knowing far more than 3000
structures. They are present in fungi and bryophytes.
Except for a few drugs that contain them, and artemisinin
derivatives, they have almost no therapeutic uses. The
biological properties of these lactones includes antibac-
terial and antifungal activities, antiparasitic, anthelmintic,
anti-inflammatory and cytotoxic[1-3]. Some of these lac-
tones isolated from different Asteraceae species have
also shown aromatase inhibitory activity[4].
A useful method to obtain new molecules with po-
tential biological activity is the conversion of organic
compounds of known structure, using the enzyme po-
tential of microorganisms such as fungi and bacteria,
and also plant cells. This technique is known as biotrans-
formation, and enzymes act as catalysts, with the ad-
vantage that they are friendly to the environment, oper-
ate under mild conditions and have a high tolerance to a
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variety of natural and unnatural substrates[5]. The reac-
tions involved in these transformations include hydroly-
sis, reduction, oxidation, carbon-carbon bond forma-
tion, addition and elimination, halogenation and
dehalogenation[6].
Continuing with our goal to find related natural prod-
ucts compounds with cytotoxic or antioxidant activity,
we have chosen (-)-achalensolide (1) a sesquiterpene
lactone isolated from Stevia achalensis[7]. This com-
pound was never before biotransformed, and has only
been tested showing aromatase inhibitory activity[4].
At this time we used the phytopathogenic fungi
Penicillium sp. and Rhizopus sp. as a source of en-
zymes to modify the structure of compound (1). These
fungi have already demonstrated their ability to trans-
form terpenes[8-13].
Here we report the transformation of (-)-
achalensolide (1) to the reduced metabolite 11â,13-
dihydroachalensolide (2) by the aforementioned fungi
and antioxidant and cytotoxic activities of both com-
pounds as compared to reference substances.
EXPERIMENTAL
Microorganism and media
Penicillium sp. and Rhizopus sp. from the culture
collection of the Laboratory of Mycology, Department
of Microbiology and Immunology, National University
of Río Cuarto, (Córdoba, Argentina) were used for
screening experiments.
The microorganisms were stored on Sabouraud dex-
trose agar (Britania Laboratories, Buenos Aires, Ar-
gentina) slants at 10°C. Liquid medium for screening
and preparative-scale (scale up) experiments was po-
tato-dextrose broth (PDB) (Britania Laboratories,
Buenos Aires, Argentina) sterilized at 121°C for 20
minutes.
Equipment
Hydrogen-1 (1H) and carbon-13 (13C) nuclear
magnetic resonance (NMR) spectra were recorded on
an Avance II AV400 spectrometer (Bruker BioSpin
GmbH, Rheinstetten, Germany) in deuterated chloro-
form with tetramethylsi­lane as the internal standard.
Thin layer chromatography was performed on Kieselgel
60 GF254 precoated plates (Merck and Co, Inc,
Whitehouse Station, NJ) DCM:Me2CO (9.5:0.5 vol-
ume/volume [v/v]) as elution solvent mixture. Detection
was achieved by spraying with p-
anisaldehyde:EtOH:AcOH:H2SO4 (0.1:17:2:1 v/v/v/v)
followed by heating at 150°C. Column chromatogra-
phies were run using Kieselgel 60 H (Merck) as the
stationary phase. All organic solvents were distilled prior
to use. The starting material achalensolide (1) was iso-
lated from Stevia achalensis, as a white solid as previ-
ously described[7].
Biotransformation
Screening experiments were done following a stan-
dard two-stage protocol, previously described[14].
The preparative scale transformation was performed
in five 1 L Erlenmeyer flasks containing 400 mL of steril-
ized liquid medium and then incubated at 25-30°C. (-)-
Achalensolide (1) was added to a final concentration of
0.2 mg/mL as a 1.5% solution in DMSO:EtOH (5:1, v/
v) and the fermentation was continued for 12 days. The
starting material disappearance was detected by TLC.
Extraction and purification
After the time above mentioned, extraction was
carried out as described before[15], giving an oily resi-
due (429.7 mg).
After purification by column chromatography using
DCM:Me2CO (100:0 to 89:11v/v) as mobile phase a
mixture of starting material (1) and the compound (2)
was obtained (214.8mg). Further purification by PTLC
using DCM:Me2CO (9:1; v/v) as mobile phase was
carried out. The compound 11â,13-
dihydroachalensolide (2) was obtained as white needle
shape crystals (26.5mg), mp 120-123°C (crude). IR
(KBr) ícm-1: 1775 (C=O, ã-lactone), 1680 (C=O, á,â-
unsaturated ketone), 1440, 1410, 1375, 1360, 1310,
Figure 1 : Structure of (-)-Achalensolide (1) and the  metabo-
lite (2)
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1230, 1120, 1060, 1020, 910, 870, 750, 500, 400.
The physical properties were in accordance to biblio-
graphical data[7] allowing to assign the structure showed
in figure 1, with â stereochemistry for proton at car-
bon-11 based on 1H NMR (400.3 MHz, deuterated
chloroform) and 13C NMR (100.03 MHz, deuterated
chloroform) spectra.
These chemical shifts are listed in TABLE 1.
compound obtained was determined by Artemia salina
method [15]. Achalensolide (1) and 11â,13-
dihydroachalensolide (2) were tested at 100, 75, 50,
25 and 10 ppm.
TABLE 1 : 1H (400.3 MHz) and 13C (100.03 MHz) NMR spec-
tral data of compound 2
Carbon äH (J) 
äC 
(ppm) 
(HSQC) 
HMBC 
1 2.91, brs 46.9 C4-C5-C7-C8 
2 1.98, dd (4.0;18.1) 2.38, dd (6.0; 18.1) 37.1 C1-C5 
3  207.5  
4  140.0  
5  168.8  
6 2.58, dd (4.7; 14.0) 2.80, dd (4.7; 14.0) 26.58 
C13-C10-C9-C11- 
C7-C1 
C7-C1-C11 
7 2.14, m 44.62  
8 4.53, ddd (4.5;7.5;12.1) 80.0 C7-C10-C11-C12 
9 1.57, m 1.24, m 33.4 
C1-C7-C8-C10-
C14 
10 2.11, m 27.4  
11 2.15, m 35.45  
12  178.12  
13 1.24, d (7.1) 13.6 C7-C11-C12 
14 0.97, d (7.1) 19.6 C1-C9-C10 
15 1.65, d (2.1) 8.5 C3-C4-C5 
Note: J values in Hz; spectra in deuterated chloroform with
tetramethylsilane as the internal standard.
Abbreviations: ä chemical shift; HSQC heteronuclear single
quantum correlation; HMBC homonuclear multiple-bond
correlation
Antioxidant activity
The antioxidant activities of substrate (1) and its
metabolite (2) were tested using the 1,1-diphenyl-2-
picrylhydrazyl (DPPH) radical method in the same way
as described previously[15]. Concentrations of 0.005,
0.01, 0.015 and 0.02 % (w/v) were used and com-
pared to a reference compound (ascorbic acid). Re-
sults are shown in TABLE 2.
Citotoxic activity
The citotoxic avtivity of starting material and the
TABLE 2 : Antioxidant activity of compounds 1 and 2 by 1,1-
diphenyl-2-picrylhydrazyl methoda
Compound Concentration (%) 
A at 
510nm 
Scavenging 
activity(% 
inhibition 
DPPH) 
EC50b 
(mg/mL) 
AE = 
1/EC50 
0.02 0.193 43.6 
0.015 0.196 43 
0.01 0.2 40 
1 
0.005 0.205 39 
0.25 4 
0.02 0.416 36 
0.015 0.420 35 
0.01 0.428 32 
2 
0.005 0.433 29 
0.35 2.85 
0.02 0.012 99 
0.015 0.017 98 
0.01 0.025 97 
Ascorbic 
acid 
0.005 0.035 96 
0.02 50 
Control  0.289    
Notes: aValues expressed are mean ± standard deviation of three
parallel measurements; bconcentration of substrate that causes
50% loss of 1,1-diphenyl-2-picrylhydrazyl activity.
Results are expressed as mortality percentage given
by the formula: Mortality(%) = ([%mortality of test-
%mortality control]/[100-%mortality control]) x 100
and compared to caffeine (see TABLE 3).
RESULTS AND CONCLUSIONS
The target compound (-)-achalensolide (1) was
screened in small scale to get its transformation with
two pure strains of Penicillium sp. and Rhizopus sp.
After that only one metabolite was seen in both cases
when checked by TLC. Then biotransformation was
scaled up on PDB at 25-30°C and after the time and
purification technique above mentioned the pure me-
tabolite (2) (6.5% yield) was obtained. IR spectrum
showed a peak at 1680 cm-1 from carbonyl of á,â-
unsaturated ketone and 1775 cm-1 due to carbonyl of
saturated ã-lactone. No band due to hydroxyl group
was seen showing that lactone ring was not hydrolyzed.
The 1H-NMR spectrum showed a signal at ä = 2.15
ppm as multiplet assigned to proton-11 and a doublet
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at ä = 1.24 ppm (J = 7.1) assigned to protons of car-
bon-13 methyl group. These are new signals when com-
pared with (-)-achalensolide (1) spectrum where it can
be seen at ä = 5.71 and 6.39 ppm two doublets due to
carbon-13 methylene group[7], absents in the spectrum
of product 2. The signals of 13C-NMR were assigned
through the heteronuclear single quantum correlation
spectrum. A signal at ä = 35.45 ppm was attributed to
carbon-11 and the new methyl group of carbon-13
showed a signal at ä = 13.6 ppm. Signal at ä = 207.5
ppm due to carbonyl group of cyclic ketone was not
modified, and signal at ä = 178.12 ppm due to carbo-
nyl group of lactone ring was downfield, when com-
pared with the same functional groups of starting com-
pound (1). Signals at ä = 138.4 and 123.4 ppm due to
exocyclic carbon-carbon double bond of starting com-
pound are absent. Stereochemistry of the new quiral
carbon-11 was determined comparing the 13C NMR
spectrum with those of the same compound and its di-
astereomer[7]. Considering the signals at ä = 44.62 ppm
(carbon-7), 33.4 ppm (carbon-9), 27.4 ppm (carbon-
10), 35.45 ppm (carbon-11) and basically 13.6 ppm
(carbon-13), close to those of the same stereoisomer
already published, we can ensure methyl group of car-
bon-11 has the á configuration.
The presence of the new carbon-13 methyl group
was corroborated by heteronuclear multiple-bond cor-
relation spectrum since these protons (ä = 1.24 ppm)
showed important correlations with carbon-7 (ä = 44.62
ppm), carbon-11 (ä = 35.45 ppm) and carbon-12 (ä
= 178.12 ppm). See figure 2.TABLE 3 : Artemia salina test of compounds 1 and 2
Compound Concentration (ppm) 
% 
mortality 
LD50 
(ppm)a 
100 34 
75 33 
50 27 
25 14 
1 
10 7 
22.69 
100 33 
75 20 
50 17 
25 9 
2 
10 4 
24.64 
Note: aConcentration of compound that causes 50% death of
Artemia salina nauplii.
Abbreviation: LD50, median lethal dose.
Figure 2 : Heteronuclear multiple-bond correlation for com-
pound 2
From the results obtained, it can be seen that the
enzymes expressed in the used microorganism are
enoate reductases, which have allowed the reduction
of the exocyclic double bond of the lactone ring with
the stereochemistry shown.
Antioxidant activity assay showed the product (2)
has slightly less activity than the substrate (1), which
suggests that the structural change introduced is respon-
sible for the decrease.
By contrast, in the brine shrimp test product (2)
showed slightly higher toxicity than the starting com-
pound (1), due to the reduction of the exocyclic double
bond of the lactone ring.
We can conclude that both microorganisms reduced
(-)-achalensolide (1) in a regio and stereoselective man-
ner, since only the exocyclic double bond of the lactone
ring was hydrogenated and the single stereoisomer
11â,13-dihydroachalensolide (2) was detected, com-
pared to natural product previously isolated[7]. More-
over it is important to note that enzymatic reduction of
(1) is verified by the more hindered á side like the chemi-
cal one, whereas the catalytic reduction is produced by
the opposite â side[7]. Then it could be assumed that
the enzyme which catalyzes the reaction allows anchoring
the substrate masking the â face, so that only the á side
is exposed to the hydride transfer[16].
This is the first report of the biotransformation of (-
)-achalensolide (1) and the first time an activated car-
bon-carbon double bond was reduced with pure strains
of fungi of the genus Rhizopus and Penicillium. How-
ever, the structural modification achieved in the prod-
uct, did not improve biological activities tested here.
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